Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
US Army

Generated: December 18, 2017

DrugPatentWatch Database Preview

Amikacin sulfate - Generic Drug Details

« Back to Dashboard

What are the generic sources for amikacin sulfate and what is the scope of amikacin sulfate patent protection?

Amikacin sulfate
is the generic ingredient in four branded drugs marketed by Abbott, Emcure Pharms Ltd, Fresenius Kabi Usa, Hospira, Igi Labs Inc, Sagent Pharms, Teva Pharms Usa, West-ward Pharms Int, and Apothecon, and is included in twenty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for amikacin sulfate. Five suppliers are listed for this compound.

Pharmacology for amikacin sulfate

Medical Subject Heading (MeSH) Categories for amikacin sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms IntAMIKACIN SULFATEamikacin sulfateINJECTABLE;INJECTION063274-001May 18, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms IntAMIKACIN SULFATEamikacin sulfateINJECTABLE;INJECTION063275-001May 18, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
ApotheconAMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERamikacin sulfateINJECTABLE;INJECTION050618-001Nov 30, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
HospiraAMIKACIN SULFATEamikacin sulfateINJECTABLE;INJECTION063350-002Jul 30, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Emcure Pharms LtdAMIKACIN SULFATEamikacin sulfateINJECTABLE;INJECTION204040-001Dec 12, 2013APRXNoYes► Subscribe► Subscribe► Subscribe
Fresenius Kabi UsaAMIKACIN SULFATEamikacin sulfateINJECTABLE;INJECTION205605-001Dec 9, 2015APRXNoNo► Subscribe► Subscribe► Subscribe
Sagent PharmsAMIKACIN SULFATEamikacin sulfateINJECTABLE;INJECTION203323-001May 12, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms UsaAMIKACIN SULFATEamikacin sulfateINJECTABLE;INJECTION064045-001Sep 28, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
ApotheconAMIKINamikacin sulfateINJECTABLE;INJECTION062311-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
HospiraAMIKACIN SULFATEamikacin sulfateINJECTABLE;INJECTION064098-001Jun 26, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: